Potential conflict of interest: Dr. Asahina is on the speakers' bureau of Chugai Pharma and MSD, and received research funding from Daiichi-Sankyo and Chugai Pharma. Dr. Asahina and Dr. Kakinuma belong to a donation-funded department funded by Chugai Pharma, Toray, Bristol-Myers Squibb, Dainippon-Sumitomo Pharma, and MSD.
α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C
Version of Record online: 19 AUG 2013
Copyright © 2013 by the American Association for the Study of Liver Diseases
Volume 58, Issue 4, pages 1253–1262, October 2013
How to Cite
Asahina, Y., Tsuchiya, K., Nishimura, T., Muraoka, M., Suzuki, Y., Tamaki, N., Yasui, Y., Hosokawa, T., Ueda, K., Nakanishi, H., Itakura, J., Takahashi, Y., Kurosaki, M., Enomoto, N., Nakagawa, M., Kakinuma, S., Watanabe, M. and Izumi, N. (2013), α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C. Hepatology, 58: 1253–1262. doi: 10.1002/hep.26442
Supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and the Japanese Ministry of Welfare, Health, and Labor.
- Issue online: 1 OCT 2013
- Version of Record online: 19 AUG 2013
- Accepted manuscript online: 8 APR 2013 04:51AM EST
- Manuscript Accepted: 4 APR 2013
- Manuscript Received: 19 FEB 2013
Additional Supporting Information may be found in the online version of this article.
|hep26442-sup-0001-suppfig1.tif||15112K||Supplementary Information Figure 1. Predictive values for platelet counts and aspartate aminotransferase to platelet ratio index (APRI) in patients without advanced fibrosis (A) Receiver operator characteristics (ROC) curve for prediction of HCC in overall patients. (B) Cumulative incidence of HCC stratified by platelet counts in patients without advanced fibrosis. (log-rank test: p= 0.0001). (C) Cumulative incidence of HCC stratified by APRI in patients without advanced fibrosis. (log-rank test: p< 0.0001).|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.